Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chacruna is a U.S.-based 501(c)(3) nonprofit organization focused on research, education, public discourse, and advocacy related to psychedelic plant medicines and the broader field of psychedelic science. Rather than developing drug assets, the organization produces original social-science research, publishes educational content through the Chacruna Chronicles, and runs trainings, workshops, and conferences for practitioners, researchers, and the public. Its work emphasizes psychedelic justice, Indigenous reciprocity, protection of sacred plants, and the cultural, legal, and ethical dimensions of psychedelic use. Chacruna also seeks to bridge traditional ceremonial contexts with emerging clinical and therapeutic settings by bringing anthropological, social-science, and Indigenous perspectives into healthcare and psychedelic-therapy conversations. The organization appears active and operating primarily from Northern California with strong ties to Brazil and Mexico.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chacruna.